Expression of Cell Division Cycle Protein 45 in Tissue Microarrays and the CDC45 Gene by Bioinformatics Analysis in Human Hepatocellular Carcinoma and Patient Outcomes

Hui-Ping Lu; Xiu-Fang Du; Jian-Di Li; Su-Ning Huang; Rong-Quan He; Hua-Yu Wu; Ming-Fen Li; Wei-Zi Wu; Ji-Tian Chen; Wei-Jia Mo; Gang Chen

doi:10.12659/MSM.928800

24 February 2021 : Clinical Research

Expression of Cell Division Cycle Protein 45 in Tissue Microarrays and the CDC45 Gene by Bioinformatics Analysis in Human Hepatocellular Carcinoma and Patient Outcomes

Hui-Ping Lu^1ABCDEFG, Xiu-Fang Du^1BCDEF, Jian-Di Li^1BCDEF, Su-Ning Huang^2ADEF, Rong-Quan He^3ABDEF, Hua-Yu Wu^4ABDEF, Ming-Fen Li^5BCDEF, Wei-Zi Wu^6CDEF, Ji-Tian Chen^6BCDE, Wei-Jia Mo^1ABCDEFG, Gang Chen^1ABCDEFG*

DOI: 10.12659/MSM.928800

Med Sci Monit 2021; 27:e928800

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 7 The clinical implications of CDC45 genetic alterations. (A) The oncoprint of CDC45 in 360 patients/complete samples from 442 cases of hepatocellular carcinoma (HCC). CDC45 was altered in 34 (9%) cases. Patients with the CDC45 genetic alteration were more likely to have poor lifespan (B, for overall survival; C, for disease-free survival).

Back to the Article

Expression of Cell Division Cycle Protein 45 in Tissue Microarrays and the CDC45 Gene by Bioinformatics Analysis in Human Hepatocellular Carcinoma and Patient Outcomes

Your Privacy